Log in to save to my catalogue

Perfluorochemical‐facilitated plasminogen activator delivery to the airways: A novel treatment for i...

Perfluorochemical‐facilitated plasminogen activator delivery to the airways: A novel treatment for i...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_bad4ee72bd4245768ebac4aaa4449de0

Perfluorochemical‐facilitated plasminogen activator delivery to the airways: A novel treatment for inhalational smoke‐induced acute lung injury

About this item

Full title

Perfluorochemical‐facilitated plasminogen activator delivery to the airways: A novel treatment for inhalational smoke‐induced acute lung injury

Publisher

United States: John Wiley and Sons Inc

Journal title

Clinical and translational medicine, 2020-03, Vol.10 (1), p.258-274

Language

English

Formats

Publication information

Publisher

United States: John Wiley and Sons Inc

More information

Scope and Contents

Contents

Background
Effective clinical management of airway clot and fibrinous cast formation of severe inhalational smoke‐induced acute lung injury (ISALI) is lacking. Aerosolized delivery of tissue plasminogen activator (tPA) is confounded by airway bleeding; single‐chain urokinase plasminogen activator (scuPA) moderated this adverse effect and support...

Alternative Titles

Full title

Perfluorochemical‐facilitated plasminogen activator delivery to the airways: A novel treatment for inhalational smoke‐induced acute lung injury

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_bad4ee72bd4245768ebac4aaa4449de0

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_bad4ee72bd4245768ebac4aaa4449de0

Other Identifiers

ISSN

2001-1326

E-ISSN

2001-1326

DOI

10.1002/ctm2.26

How to access this item